Privileges and Immunity Certification During the COVID-19 Pandemic

Viewpoint warns that the ideal of a measured, evidence-based approach to policy making appears likely to be overrun by hopes and demands for antibody testing, which raises a host of important legal, ethical, and policy concerns that will not wait for greater scientific certainty.

SPS commentary:

A second viewpoint presents a framework for analysing the ethics of immunity licenses, suggesting they should not be evaluated against baseline of normalcy, i.e. uninfected free movement, but against alternatives of enforcing strict public health restrictions for many months or permitting activities that could spread infection, both of which exacerbate inequalities and impose serious burdens.


Journal of the American Medical Association

Resource links:

Ethics viewpoint